The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market, By Product Type (Endotherapy Devices, Endoscopes, Imaging Devices, and Others), Modality (Single Use, Standalone, Handheld), Procedure (Biliary Sphicterectomy, Biliary Stenting, Biliary Dilation, Pancreatic Duct Stenting, Pancreatic Sphicterectomy), Application (Bile Duct, Pancreas, Gall Bladder, Liver and Others), End User(Hospitals, Ambulatory Surgical Center, Diagnostic Laboratories and Others), Facility Type (Large, Medium and Small), Distribution Channel (Direct Tenders, Third Party Distribution, and Retail Sales), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of the Middle East and Africa) Industry Trends and Forecast 2028.
Market Analysis and Insights: Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is expected to grow in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.0% in the forecast period of 2021 to 2028 and is expected to reach USD 103.28 million by 2028 from USD 78.44 million in 2020. The high prevalence of pancreatic and biliary diseases is likely to be the major drivers that propel the market's demand in the forecast period.
The high prevalence of chronic diseases, pancreatic tumor, rising government expenditure on healthcare infrastructure, favourable reimbursement scenario are the driving the market growth. However, the stringent government rules for approval of devices are restraining the growth of the market. The rising awareness among people for early diagnosis and treatment of disease is acting as opportunity for the market. The side effects associated with ERCP procedure is acting as challenge for the market.
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Scope and Market Size
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is categorized into seven notable segments based on product type, modality, procedure, application, end user, facility type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. In 2021, the endotherapy devices segment is expected to dominate the market due to the availability of various types of equipment. Big players are manufacturing this equipment in the Middle East and Africa market.
- On the basis of modality, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld. In 2021, the single-use segment is expected to dominate the market because there is no risk of disease transmission from one patient to another while using single-use devices.
- On the basis of procedure, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy. In 2021, the biliary sphincterotomy segment is expected to dominate the market because of the high prevalence of pancreatic tumors in the Middle East and Africa region.
- On the basis of application, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. In 2021, the bile duct segment is expected to dominate the market because of the high prevalence of biliary diseases in the Middle East and Africa region.
- On the basis of end user, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. In 2021, the hospital's segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by medical device companies to expand their capabilities in the ERCP market.
- On the basis of facility type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. In 2021, the large segment is expected to dominate the market due to the high demand for ERCP procedures in the Middle East and Africa.
- On the basis of distribution channel, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third-party distribution, and retail sales. In 2021, the direct tender segment is expected to dominate the market because of significant growth due to the overall control over sales and revenue processes and direct interactions with customers.
The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Country Level Analysis
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is analyzed, and market size information is provided by product type, modality, procedure, applications, end-user, facility type, and distribution channel.
The countries covered in the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market report are South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, and the Rest of the Middle East and Africa.
The Middle East and Africa are expected to grow with a CAGR of 4.0% in the forecasted periods as in the Middle East and African countries; the high prevalence of biliary diseases and government support. South Africa is expected to dominate in the market in the Middle East and Africa market. South Africa is one of the leading countries to inculcate the endoscopic retrograde cholangiopancreatography devices market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The Presence of Advanced Technology and Strategic Initiatives Taken by Players are Creating New Opportunities in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market also provides you with detailed market analysis for every country's growth in a particular industry with ERCP products sales, the impact of advancement in the market, and changes in regulatory scenarios with their support for the market. The data is available for the historical period 2010 to 2019.
Competitive Landscape of the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Devices Market Share Analysis
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the endoscopic retrograde cholangiopancreatography devices market.
The major companies providing the Middle East and Africa endoscopic retrograde cholangiopancreatography devices are Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, Hospiline Equipments among others.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The strategic initiatives by market players and new technological advancements for endoscopic retrograde cholangiopancreatography devices are bridging the gap for a variety of treatments.
For instance,
- In December 2017, BD has completed the acquisition of C. R. Bard, Inc. This has helped strengthening B.D.’s business and accelerate its growth trajectory, particularly in the long term, which is anticipated to enhance leadership in Africa
- In December 2020, Johnson & Johnson Services, Inc. announced that it has participated in 39th annual J.P. Morgan Healthcare Conference. This helped the company to give the correct knowledge about their product and would help the company to further grow in coming years
Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the endoscopic retrograde cholangiopancreatography devices market, which also benefits the organization to improve their offering for the market.
SKU-
